Stock listing
BIOA Stock Price, News, Filings & Events — Bioage Labs, Inc.
Selected listing: BIOA · NASDAQ · USD · US
This page tracks Bioage Labs, Inc.'s BIOA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BIOA:NASDAQ. BIOA:NASDAQ is the stock-level entry point for investors researching Bioage Labs, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bioage Labs, Inc. is a public company traded under the ticker BIOA on the American market. The company has a market capitalization of approximately $1.08 billion. Bioage Labs focuses on developing therapies to extend healthy lifespan and address age-related diseases.
- Ticker
- BIOA:NASDAQ
- Asset type
- Stock
- Market cap
- $1.10B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Bioage Labs, Inc. BIOA:NASDAQ stock context
This page tracks Bioage Labs, Inc.'s BIOA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BIOA:NASDAQ. BIOA:NASDAQ is the stock-level entry point for investors researching Bioage Labs, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bioage Labs, Inc. is a public company traded under the ticker BIOA on the American market. The company has a market capitalization of approximately $1.08 billion. Bioage Labs focuses on developing therapies to extend healthy lifespan and address age-related diseases.
Latest news from Bioage Labs, Inc.
BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular...
September 8, 2026
BioAge Labs Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 5, 2026
HitGen Partner BioAge Labs Doses First Participant in Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor for Cardiovascular Risk Redu...
July 14, 2026
BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in ...
June 16, 2026
BioAge Labs Reports First Quarter 2026 Financial Results and Provides Business Updates
May 8, 2026
Research Bioage Labs, Inc.
Bioage Labs, Inc. investor report
Review AI stock analysis and investor report context for BIOA:NASDAQ.
Bioage Labs, Inc. company profile
View the public company page for Bioage Labs, Inc. on 6ix.
Bioage Labs, Inc. news
Read company news and market updates connected to Bioage Labs, Inc..
Bioage Labs, Inc. investor events
Find investor webinars, events, and replay context for Bioage Labs, Inc..
Alternate listings
Y7G:GETTEX
DE · EUR
Alternate listing for Bioage Labs, Inc.; the primary context on this page is BIOA:NASDAQ.
A40D7P:LS
DE · EUR
Alternate listing for Bioage Labs, Inc.; the primary context on this page is BIOA:NASDAQ.
BIOA:BOATS
US · USD
Alternate listing for Bioage Labs, Inc.; the primary context on this page is BIOA:NASDAQ.
Y7G:TRADEGATE
DE · EUR
Alternate listing for Bioage Labs, Inc.; the primary context on this page is BIOA:NASDAQ.
A40D7P:LSX
DE · EUR
Alternate listing for Bioage Labs, Inc.; the primary context on this page is BIOA:NASDAQ.
Y7G:FWB
DE · EUR
Alternate listing for Bioage Labs, Inc.; the primary context on this page is BIOA:NASDAQ.
Y7G:DUS
DE · EUR
Alternate listing for Bioage Labs, Inc.; the primary context on this page is BIOA:NASDAQ.
Y7G:HAM
DE · EUR
Alternate listing for Bioage Labs, Inc.; the primary context on this page is BIOA:NASDAQ.
Y7G:MUN
DE · EUR
Alternate listing for Bioage Labs, Inc.; the primary context on this page is BIOA:NASDAQ.
Y7G:SWB
DE · EUR
Alternate listing for Bioage Labs, Inc.; the primary context on this page is BIOA:NASDAQ.